AVIX presents ventures at different stages of scientific, manufacturing and commercial development. Website content does not provide medical advice or guarantee scientific, regulatory, commercial or financial outcomes.
Document information
Last updated 26 July 2026. This disclaimer explains the limits that apply when interpreting scientific, health, commercial and forward-looking information on the AVIX Pharmaceuticals website.
01 · Portfolio status
T-Booster is a food-supplement programme with human-study participation complete; Green Antibiotics remains an in-vitro animal-health discovery programme; AVIX Water is a food-and-beverage platform moving towards qualified manufacturing.
02 · Scientific findings
Laboratory, clinical and participant-reported information must be interpreted within the design and maturity of each programme. Early or incomplete findings may change after further analysis, replication or validation.
03 · Health claims
Nothing on this website establishes that an AVIX venture diagnoses, treats, cures or prevents disease unless a future authorised claim explicitly states otherwise. Venture-specific claims must remain within their regulatory status.
04 · Commercial information
Market figures, target dates, manufacturing plans, launch pathways, fundraising discussions and partnership scenarios are forward-looking assumptions and are not guarantees of approval, launch, revenue, valuation or investment return.
05 · Investment
Nothing on this website constitutes an offer, invitation or inducement to acquire securities or make an investment. Any formal investment process should rely on appropriate legal, financial and scientific diligence.
06 · Clarification
Third-party links are provided for context. Request clarification at hello@avixpharma.com before relying on a scientific, health, legal, regulatory, commercial or investment statement.
